Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2025-09-10 Report Publication Anno…
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Notice of interim results
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from EKF Diagnostics Holdings PLC regarding the upcoming release of their interim results and an invitation to an investor presentation. It does not contain the actual financial report, but rather serves as a notification of the publication date and event. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-09-10 English
Hematology contracts signed worth EUR 4.65m
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from EKF Diagnostics Holdings PLC regarding the signing of new hematology contracts. It is a corporate news release detailing business operations and contract wins, which does not fit into specific categories like financial reports, proxy statements, or director dealings. Therefore, it is classified as a general regulatory filing.
2025-08-26 English
H1 2025 Trading Update
Earnings Release Classification · 1% confidence The document is an 'H1 2025 Trading Update' issued by EKF Diagnostics Holdings PLC. It provides preliminary financial highlights (revenue, gross margins, EBITDA, and cash position) for the six-month period ending June 30, 2025, ahead of the full interim report release scheduled for September 16, 2025. According to the filing definitions, an initial announcement of quarterly/periodical financial results (key highlights only) is classified as an Earnings Release (ER). H1 2025
2025-07-28 English
Cancellation of Treasury Shares & TVR
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and contains information typical of a regulatory news service announcement from the London Stock Exchange. The content explicitly details the 'Cancellation of Treasury Shares & TVR' and provides the resulting total number of voting rights, which is information relevant for shareholders determining notification requirements under the FCA's Disclosure and Transparency Rules. This type of immediate, specific corporate action announcement that is distributed via RNS and does not fit into a more specific category like Director's Dealing (DIRS) or Share Issue (SHA) is best classified as a general Regulatory Filing (RNS). Although it relates to share capital changes (POS/SHA), the primary function here is the official notification of the cancellation and the resulting denominator for shareholder calculations, making RNS the most appropriate general regulatory category.
2025-06-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the footer mentioning RNS and the London Stock Exchange. The content details a 'NOTIFICATION OF MAJOR HOLDINGS' by Schroders PLC, showing a change in their percentage of shares outstanding (crossing the 5% threshold). This type of filing, reporting changes in significant share ownership, directly corresponds to the Major Shareholding Notification category. Therefore, the filing type code is MRQ.
2025-06-17 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement (3380 characters) released via RNS (RNS Number: 8531K) on June 2, 2025. The content explicitly states the 'total issued share capital' and the 'total number of Ordinary Shares carrying voting rights' as required by the Financial Conduct Authority's Disclosure and Transparency Rules. This type of mandatory notification regarding the total number of shares for voting purposes is a standard regulatory disclosure. Since it is a short, specific regulatory update that doesn't fit into the major categories (like 10-K, ER, or DIV), and it is distributed via the RNS system, it best fits the general Regulatory Filings category (RNS) or potentially a specific category if one existed for voting rights, but based on the provided definitions, RNS is the most appropriate general regulatory announcement fallback, although DVA (Declaration of Voting Results & Voting Rights Announcements) is also a possibility. However, DVA is defined as 'Official results from shareholder votes at any general meeting'. This document is a standing notification of the denominator for future votes, not the result of a past vote. Therefore, RNS is the most accurate classification for this routine regulatory update.
2025-06-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.